Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally tolerated it well, according to data published in The Lancet Respiratory Medicine.“Vanzacaftor-tezacaftor-deutivacaftor was safe and well tolerated and maintained FEV1 percent predicted from elexacaftor/tezacaftor/ivacaftor baseline with further improved CFTR
Among patients with obstructive sleep apnea, those treated with sleep surgery vs. CPAP had decreased odds for motor vehicle accident incidence, according to results published…
Following the 2025 European Respiratory Society (ERS) elections, which saw ERS members vote to elect their preferred candidates for National Delegate, Assembly Head and Secretary,…
The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal antibody product — but it may not be…
You’ve successfully added to your alerts. You will receive an email when new content is published. Back to Healio We were unable to process your…
U.S. News & World Report recently released its ranking for the top heart-healthy diets as ranked by medical doctors, registered dietitians and nutritional epidemiologists.A panel…
To take part in this event, you must register in advance. REGISTER NOW Access the live stream WATCH LIVE 25 February, 2025 | OnlineOrganisers:…
KOLOA, Hawaii — Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision,…
How will the change in the White House impact the ATS policy positions and what can members do to become more engaged?Gary Ewart, 30-year chief…
Adults with type 2 diabetes using a GLP-1 drug have a similar risk for thyroid cancer as those using other diabetes drugs, though increased thyroid…
